Filter
2291
Filtered Results: 2291
Text search:
clinical
trials
Featured
Recommendations
240
New Publications
396
Language
Document type
No document type
1162
Guidelines
435
Studies & Reports
382
Manuals
103
Fact sheets
84
Strategic & Response Plan
56
Training Material
28
Situation Updates
14
Resource Platforms
12
Infographics
11
Brochures
2
Videos
2
Countries / Regions
India
112
Global
95
South Africa
53
Kenya
39
Western and Central Europe
39
Africa
38
Uganda
25
East and Southern Africa
25
Latin America and the Carribbean
25
Ethiopia
24
West and Central Africa
24
Sierra Leone
22
Russia
22
Nigeria
20
Zambia
20
Brazil
20
Liberia
18
Nepal
18
Malawi
18
Tanzania
17
Ukraine
17
Eastern Europe
17
Rwanda
16
Philippines
15
Zimbabwe
14
Germany
14
Indonesia
14
Ghana
13
Middle East and North Africa
13
Bangladesh
11
Mozambique
11
Namibia
11
South–East Asia Region
11
Congo, Democratic Republic of
10
Asia
10
Guinea
9
South Sudan
8
Peru
8
USA
7
Cameroon
7
Eastern Europe and Central Asia
7
Burkina Faso
6
Eswatini/ Swaziland
6
Botswana
6
Angola
6
Lesotho
6
Cambodia
5
Colombia
5
Chile
5
Albania
5
Thailand
4
Sudan
4
North America
4
United Kingdom
4
Senegal
3
Guinea-Bissau
3
Haiti
3
Syria
3
China
3
Argentina
3
Paraguay
3
Vietnam
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Iraq
2
Lebanon
2
Burundi
2
Myanmar / Burma
2
Sri Lanka
2
Laos
2
Tajikistan
2
Estonia
2
Georgia
2
France
2
Portugal
2
Morocco
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Chad
1
Ireland
1
Singapore
1
Benin
1
Ecuador
1
Greece
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Other region
1
Southern Africa
1
Canada
1
Bulgaria
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Jamaica
1
Denmark
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
562
Clinical Guidelines
353
Public Health
154
Women & Child Health
136
Key Resources
37
Pharmacy & Technologies
34
Capacity Building
21
Toolboxes
COVID-19
305
Mental Health
291
HIV
236
TB
187
NCDs
96
NTDs
94
AMR
72
Ebola
62
Pharmacy
59
Caregiver
57
Rapid Response
56
Disability
27
Planetary Health
24
Global Health Education
22
Refugee
18
Polio
13
Conflict
13
Cholera
11
Zika
11
Health Financing Toolbox
8
Natural Hazards
4
Social Ethics
4
Specific Hazards
2
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven ...
The document "Management of Type 2 Diabetes Mellitus" provides comprehensive guidelines for the diagnosis, prevention, and treatment of type 2 diabetes in adults. It emphasizes the importance of individualized glycemic targets, lifestyle interventions like diet and exercise, and the use of medicatio...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
Treatment Recommendations for Adult Inpatients
These guidelines have been prepared by the Sub directorate: Maternal Health for the guidance of health workers (doctors and midwives) providing obstetric, surgical and anaesthetic services for pregnant women in district clinics, health centres and district hospitals. These guidelines are intended fo...
Drugs & Therapy Perspectives vol.36 (2020) 6
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
